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Hearing devices may be classified as sound-producing hearing aids (SPHAs), 
electrically stimulating devices (cochlear implants, CIS), and vibratory hearing aids 
(VHAS).~~ Because patients may lose physiologic cochlear amplification (positive 
recruitment, loss of otoacoustic emissions [OAE] hearing devices for the treat- 
ment of sensorineural hearing loss (SNHL) are used as signal amplifiers. Sound- 
producing hearing aids are not in contact with the ear drum, whereas VHAs 
(e.g., Entific BAHA) are directly coupled to the patient's skull or ossicular chain 
(e.g., Eon-MEI, Symphonix Vibrant, Implex TICA). VHA is designated a vibratory 
amplifier implant (VAI). 
The totally implantable communication assistance (TICA) device is a 
European-approved totally implantable vibratory amplifier implant. It picks up 
the sound signal transcutaneously from the external auditory canal (EAC) near the 
ear drum, amplifies the signal, and transduces the signal into microvibrations that 
are delivered to the ossicular chain. Development, technical detai l~,2~-~~,  25 surgical 
technique, patient selection criteria, and clinical results of the version LZ 3001 have 
been published55, 56 and are reviewed in this article. Since 1998, the TICA device has 
been used for the surgical treatment of moderate to severe high-frequency SNHL 
in Europe.55 
International research that led to the present-day vibratory hearing aids be- 
gan as early as 1935.'. 4, 29-31* 34-44, 46, 49, 50 These research efforts have shown that 
replacing sound stimulation of the ear by vibratory stimulation of the ossicular 
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chain may result in a surprisingly clear (low-distortion) hearing impression that is 
matched only by high-performance loudspeakers. 
There are various ways, other than a loudspeaker, to drive the ossicular chain 
by a vibratory device. Rather than placing the vibratory part of a VHA on the ear 
drum, the TICA uses an ossicular chain coupling (OCC) to implant the actuating vi- 
brator. The implantation of all parts of the VHA results in a totally implantable (TI) 
VAI coupled to the ossicular chain. A TI-VAI may be helpful to hearing-impaired 
persons who cannot benefit from sound-producing hearing aids for medical, psy- 
chologic, audiologic, or professional reasons. 
In some patients, conventional hearing aids may have fundamental disad- 
vantages that prevent patients from using them.45 The ear mold can create an 
unpleasant sensation of ear occlusion and pressure. In some patients the ear mold 
can induce inflammation of the EAC. To prevent the sensation of occlusion, the 
ear mold may be inserted loosely, leading to unwanted feedback or to reduced 
efficacy of the hearing aid. In addition, some patients find the acoustic distortion 
produced by the closure of the EAC and the resulting low intelligibility of speech 
to be intolerable. Certain professions or jobs (e.g., in music, sports, or telephone 
centers) do not allow the use of hearing aids. Hearing aids are at increased risk of 
loss or destruction in work environments associated with heat, water, dust, steam, 
sweat production, or hard physical work. Finally, the patient may fear social or 
professional discrimination. 
DESIGN AND DEVELOPMENT 
The fundamental concept of the TICA device was developed by Leysieffer and 
ZennerF4 between 1990 and 1992 at the University of Tubingen, Germany. From 
1993 to 1997, after a technology transfer agreement, further development took place 
in a cooperation between teams from Tubingen University and from Implex AG 
Hearing Technology. The goal of the interdisciplinary research and development 
teams was a fully implantable hearing amplifier that can be used for patients with 
sensorineural hearing loss with intact middle ears and for patients with mixed 
hearing loss and interrupted ossicular chains. 
Design of Actuator and Sensor 
Actuator 
To develop fully implantable VAIs, most research teams looked to the devel- 
opment of high-performance batteries that are suitable for implantation and can 
supply the high energy output required by the implant for several years. The au- 
thors instead sought to create an actuator with low energy consumption (LEC) that 
would allow the use of present battery technology (Fig. 1). Mathematic modeling 
demonstrated that the power consumption of a piezoelectric transducer is much 
less than that of electromagnetic devices? The TICA heteromorph piezoelectric 
actuator prototype was designed accordingly. Unlike the biomorph piezoelectric 
transducer described by Suzuki and Yanagihara's groups,38-41, 49* 50 the TICA trans- 
ducer does not use a rod-shaped bimorph. The TICA is a circular heteromorph 
system that consists of a piezoceramic disk that is intimately linked with a tita- 
nium disk. This technology offers: 
Minimal power consumption with sufficiently high stimulation levels. (The 
electrical power consumption at full volume and broadband signals is in the 
TOTAL IMPLANTATION OF THE TICA HEARING AMPLIFIER IMPLANT 419 
Figure 1. TICA (Implex, Munich, Germany) components. Piezoelectric actuator (A) with rod 
for coupling to the incus body and clip (B)  for coupling to the long incus process. C and D, 
Membrane sensor with retention collar. Actuator and sensor possess plugs to be inserted 
into the (€and F )  main module with digitally programmable 3-channel audio-processor. Note 
pressure connector assembly (PCA) opened for sensor and actuator plugs. G, PCA closed. 
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range of 1 pW and is therefore lower than that of electromagnetic transducers 
and is even significantly less than that of the electronic components.) 
Minimal nonlinear distortions 
A hermatically sealable and biocompatible casing 
Because of its calculated diameter the actuator was designed for implantation in 
the mastoid. To transfer the actuator’s mechanical vibrations the design included 
a 0.5 mm thin titanium probe to be coupled to an ossicle in the middle ear. 
Sensor 
As described by Kodera et al,17 a membrane sensor was designed to be im- 
planted subcutaneously in the EAC near the ear drum. This implantation site uses 
the positive acoustic and audiologic characteristics of the EAC and auricle?, l7 Be- 
havioral and physiologic evidence suggests that the perceived sound spectrum, 
as modified by an external ear, provides important cues for horizontal and verti- 
cal sound localization. The external ear complements the incoming sound signal 
(e.g., with specific resonance patterns that correlate with the localization of a sound 
source). The resulting transfer functions encode spatial information about sound 
sources for input signals for the middle ear. After these signals are processed in the 
inner ear, the central auditory system can decode this information by evaluating 
the monaural cues. Ubiquitous background noise may result in different cues from 
specific directions, contributing to central noise suppression. 
The sensor design consists ofa hermetically sealed titanium cylinder with a stiff 
but flexible titanium membrane to be placed under the meatal skin. With a mem- 
brane diameter of only 4.5 mm, the cylinder is designed to be implanted in the poste- 
rior bony EAC. Sound-induced movements of the meatal skin drive the membrane. 
The stiffness of the membrane allows the membrane operation to be largely inde- 
pendent of the skin mass. The cylinder houses an internal microphone to transduce 
the motion of the membrane into electrical energy. Integrated electronics provide 
preamplification. Mathematrical modeling predicts a sensitivity of approximately 
1,5 mV/PA and a high spectral transmission bandwidth of as much as 10 kHz. 
Development of Actuator and Sensor 
Actuator 
Critical to the success of any totally implantable hearing device is the space 
within the temporal bone that is available for implantation. The final shape of the 
newly designed actuator and the sensor had to allow implantation into the human 
mastoid. The functional geometry of a consecutive series of six actuator prototypes 
was evaluated in 50 human temporal b0nes.2~ The resulting final actuator (clinical 
actuator) could be inserted in 78% of the cadavers examined (confidence interval 
61.5%-89.2%). A preoperative Schuller radiograph allows the exclusion of patients 
whose ears are too small for implantation.” The heart of the 0.4 g clinical actuator 
is a 3-mm thin titanium disk that seals the titanium casing (medical grade 2, ASTM 
F67) hermetically (gas-proof according to MIL-STD 883 D). The electromechanically 
active piezoceramic disk is located on the inside of the titanium disk. A titanium 
coupling probe 0.5 mm in diameter is mounted in the center of the exterior of the 
titanium disk.21, 22 
Sensor 
The design of the clinical sensor was developed in a similar manner as the 
actuator.23 Extensive temporal bone studies with four prototypes resulted in an 
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L-shaped clinical sensor housing allowing the 4.5-mm sensor membrane to be in- 
serted under the skin into the posterior wall of the EAC. The larger portion (8.5 x 
5.6 x 4.5 mm) of the sensor, however, is placed in the mastoid and is directed away 
from the sigmoidal sinus towards the tip of the mastoid. The L shape also allows 
coimplantation with the actuator in 78% (confidence interval 64.0%-88.0%) of the 
temporal bones investigated. A Schuller radiograph allows patient selection before 
surgery.28 
The small total mass (0.4 g) lessens the sensitivity to mechanical vibrations 
or knocks from the exterior. The sensor is protected to a large extent against the 
influences of external electromagnetic influences because of the total titanium en- 
capsulation. For further protection against electromagnetic influences, the sensor 
possesses electronic elements that ensure safe operation even in the presence of 
intense electromagnetic fields, as may occur, for example, during mobile telephone 
operation. Pure titanium also renders the module insensitive to a large extent to 
strong, static magnetic fields which can occur during MR imaging. The TICA is 
radiograph compatible (see Fig. 140). The intramastoidal part of the casing, which 
is aligned vertically, contains the electrical feedthrough. The electrical supply is 
connected perpendicularly to the feedthrough so that the leads can be handled 
without creating kinks or bending radii that are too small. The sensor can be ro- 
tated around the axis of the cylindrically shaped part as desired, to the degree the 
anatomy of the mastoid requires it. 
TECHNICAL PERFORMANCE 
The technical performance of the implant was determined by in vitro mea- 
surement~ .~*-~~ 
Mechanical Impedance 
Mechanical output impedance Z,  of the transducer lies 1 decade (20 dB, 5 kHz) 
to 2 decades (40 dB, 51 kHz) above the mechanical input impedance Z,  of middle 
ear and cochlea. Thus, the ossicular mass (80 mg) should not impair the transducer 
output level below the first resonance: mass influence is restricted to a shift of the 
resonance frequency to lower values. Furthermore, based on the actuator’s high 
mechanical impedance level in a large frequency range, the transducer displace- 
ment should be largely independent of individual variations in coupling load, up 
to the first resonance frequency. Thus, changes of load impedance (e.g., by connec- 
tive tissue growth at the coupling site) is expected to have no significant influence 
on transfer frequency response. 
Spectral Bandwidth, Displacement, and Equivalent 
Sound Pressure Level 
The transducer was calculated and optimized so that the first mechanical res- 
onance frequency lies at about 10 kHz. Figure 2 shows the resulting frequency 
response in the range of 250 Hz to 25 kHz of the transducer displacement ampli- 
tude x, in the mechanical idle mode (no-load condition). The remarkable transfer 
function, with an amplitude increase instead of a decrease in the high frequency 
range, was designed to cope with high-frequency SNHL. Transducer displacement 
was smooth, with a ripple of less than f l  dB, to about 6 kHz. Displacement was 
about 60 nm. Resonance was 10.25 kHz with a Q-factor of about 28 dB. Thus, 
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Figure 2. Actuator displacement (X,) versus frequency in a no load condition (insert) using 
laser doppler vibrometry. 
displacement amplitude increased by this factor, reaching about 1.5 pm at 10 kHz. 
Up to about 1 kHz, displacement is equivalent to a sound pressure level (SPL) 
of about 100 dB. In the higher frequency range, the unique constancy of the out- 
put displacement results in a considerable increase in equivalent SPL. Explanation 
is the physiologic displacement amplitude drop of the oval window membrane 
above 1 kHz if the middle ear is driven by sound. Sound possesses a low output 
impedance. 
By contrast, because of its high output impedance, the vibratory action of the 
implant should partly overcome the amplitude drop of the footplate. Based on 
these assumptions the equivalent SPL is calculated to be 128 dB at 5 kHz. At the 
resonance frequency the calculated maximum value lies above 160 dB equivalent 
SPL (Fig. 3). 
Further investigations simulated the situation under the mechanical load of 
middle and inner ear after implantation (Figs. 4, 5). As expected, because of the 
greater mass being moved, the resonance frequency decreased to 7.25 kHz. Dis- 
placement, however, does not drop off dramatically. Except for the resonance fre- 
quency, the displacement of 60 nm remains the same. The Q-factor of the first 
resonance (corresponding to 25 dB) decreases only slightly when compared with 
the idle mode (about 28 dB). Thus, with load, displacement amplitudes in the range 
of 1 pm are reached at frequencies around 7 kHz. The influence of encapsulating 
the coupling components in vivo (e.g., by connective tissue) was also simulated in 
vitro (Fig. 5). As expected, simulation of a mechanical frictional resistance influ- 
enced only the vicinity of the resonance. 
Distortions 
Low nonlinear distortions (harmonic distortion), unwanted resonances, and a 
minimal ripple displacement of the frequency response are important in producing 
a high-quality transfer, especially for speech and musical signals. The frequency 
response described previously was characterized by a flat curve with a small ripple 
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Figure 3. Estimated equivalent sound pressure level. Equivalent sound pressure level (SPL) 
was estimated for the actuator at maximum driving voltage (1 .O VRMS). 
indicating linear distortions below 2.5 dB with a TH distortim (THD) of 0.1% or less. 
Similar results were obtained for nonlinear harmonic distortions (Fig. 6) during 
maximum signal levels at 500 Hz to 4000 Hz. At very low stimulus frequencies 
(160 Hz), the harmonic distortion factor was as low as THD 0.05%. Achieving 
low harmonic distortions is important because nonlinear distortions may create 
problems for electromagnetic transducers (e.g., in conventional hearing aids) when 
operating at high output levels. 
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Figure 4. Actuator displacement under load. Displacement (X,) versus frequency in a simu- 
lated middle ear coupling condition. The insert shows the invitro coupling condition using an 
artificial ossicle made of stiff Silastic. 
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Figure 5. Actuator displacement in the presence of load and friction. Displacement (X,) versus 
frequency in the same coupling condition as shown in Figure 3. In this case the influence of 
possible tissue growth around the coupling area to the ossicles was simulated by using a little 
drop of silicone grease (insert). 
Dynamic Behavior 
Apart from a large, spectral bandwidth with low resonance and minimal non- 
linear distortion, the dynamics (i.e., the velocity of changes in frequency and ampli- 
tude) in the time domain of an implantable hearing aid transducer is of paramount 
importance for the transfer quality. Specifically, speech recognition and music in- 
volve the recognition of certain learned patterns of the signal envelope among 
which the onset phases are important. Signal dynamics are also relevant when the 
300 looo' Hz loo00 
Frequency 
Figure 6. Nonlinear distorsion of the actuator. Experiments were performed using contactless 
laser doppler vibrometry in the in vitro simulation corresponding to Figure 3. The transducer 
was driven with a sinusoidal voltage at 1000 Hz and 1 .O VRMS. 
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envelope of a speech signal changes drastically whithin an extremly short period 
of time (e.g., with plosives). In Figure 7, the transducer reaches a displacement 
amplitude value of about 80 nm extremely quickly (in less than 50 ps )  and then 
vibrates to its resonance frequency. When the stimulation impulse (see Fig. 19A) 
stops, after about 3 ms, the displacement envelope subsides totally. Under load, 
the transducer also reaches the maximum amplitude very swiftly (in about 50 ps). 
Release time is below 1 ms. The results suggest that the transducer has short onset 
times and a decay behavior that lies within the range of the minimal time resolution 
capacity of healthy ears. 
Sensor Transfer Function 
Experiments both in the idle mode and with skin and fascia coverings were car- 
ried out (Fig. 8). The idle mode transfer function is virtually frequency-independent 
in the total frequency range up to 8 kHz and shows a minor ripple (linear distortion) 
of only about f2.5 dB. The results suggest the highly tuned system with improved 
transfer function at high frequency, an advantage for patients with high-frequency 
SNHL. Furthermore, the first resonance frequency lies at the upper end of the trans- 
mission range. The system is governed by the stiffness of the titanium membrane 
below the resonance, indicating that an additional skin mass load reduces the res- 
onance frequency but does not affect the absolute transfer function value and thus 
does not affect the sensor sensitivity below the resonance. This hypothesis was 
confirmed by laser doppler vibrometry (LDV) measurements carried out with a 
coating of fascia, 0.5 mm of human auditory canal skin, and 1 mm of human full 
skin. As expected, the resonance frequency shifted down by about 1 kHz with a 
full skin coating. The sensitivity and the smoothness of the response below the 
resonance remained the same, however.23 
Spatial Hearing 
Directionality of the implanted sensor was measured using a KEMAR 












Figure 7. Temporal resolution of the actuator. A, Actuator driven with an electrical unipolar 
pulse of 100 w s  of 1.4 Vpeak. Impulse response was measured using laser doppler vibrometry. 
6, Transducer response in a mechanical no load condition (compare with Figure 2). C, Impulse 
response corresponding to the mechanical load simulation of Figure 3. D, Impulse response 
corresponding to the load condition as in Figure 4. 
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indicating that the sensor benefits from the unique acoustic properties of the exter- 
nal ear.E 
TEMPORAL BONE STUDIES 
Figure 10 shows the transducer coupling rod fixed to the incus body in a fresh 
human cadaver. Using an intracochlear approach LDV was carried out with the 
laser beam aiming at the center of the stapes footplate. As in the in vitro simulation 
(see Figs. 2,4,5) the first resonance frequency was at 8 kHz. Below this resonance, 
the frequency response is smooth down to the lower frequencies, with a maximal 
ripple of f2.5 dB. Thus, the transfer function of the actuator coupled to the ossicular 
chain is more or less unchanged in the footplate. Because of the high tuning of the 
actuator, a significant middle and high frequency increase in the equivalent SPL 
is also achieved. Up to about 1 kHz, the equivalent SPL La, is about 100 dB 
0 
So' 0 -  270 
Figure 9. Directional characteristic of the sensor. Sensor was positioned in an artificial ear 
canal of a KEMAR head (right). Directional characteristic of the KEMAR@ head using a stan- 
dard 2 ccm coupler (left). Frequencies: line = 1 kHz; dashed line = 2 kHz; dotted line = 4 kHz. 
Measurements were done in an unechoic chamber in free-field conditions. 
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Figure 10. Stapes displacement. Qualitative frequency response of the stapes displacement 
(X,) in a fresh temporal bone with transducer coupling to the incus body. The displacement 
measurement was done using a contactless laser doppler vibrometer centered on the stapes 
footplate through an intracochlear access from the cranial side. 
SPL. Above 1 kHz, the value increases and at 4 kHz reachs approximately 125 dB. 
In the resonance range of 7 kHz, values reach 150 dB SPL, and at 10 kHz the 
equivalent SPL still reachs more than 140 dB. This range of output level and the 
spectral transmission bandwidth are within the parameters required for adequate 
treatment of moderate to severe sensorineural hearing losses. 
Figure 11 shows a fresh temporal bone after implantation of the sensor. Sub- 
sequently, the meatal skinflap was laid back and soaked with Ringer’s solution. 
The resulting frequency response (L,,,ic (f)) of the implanted microphone in an un- 
echoic chamber (Fig. 12) was strikingly similar to the in vitro transfer function 
(see Fig. 8). 
ANIMAL STUDIES 
Plinkert et a13* and Weber47 performed acute and chronic studies in cats and 
dogs. In cats after preoperative (acoustic) determination of the auditory brain- 
stem response threshold, the middle ear was opened and the piezoelectric tran- 
ducer was coupled to ossicles or perilymph. Auditory brainstem responses (ABRs) 
were recorded following stimulation at the malleus, long in-process, stapes head, 
stapes footplate, or in the vestibulum. There was good correlation between the 
acoustically and mechanically evoked thresholds, including latencies. An electri- 
cal transducer voltage of 1 Vms  produced responses equivalent to sound pressure 
levels of 100 to 128 dB SPL at the tympanic membrane. 
Chronic implantations of actuator and sensor were performed in 
22 and their performance was followed for 6 months after surgery. Hearing 
threshold was monitored using ABR procedures under anesthesia. Posttrial histo- 
logic studies of the inner ears did not show adverse effects caused by the chronic 
long-term stimulation induced by the electromechanical transducers. 
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Figure 11. Sensor implanted in a fresh temporal bone. This situation was used for determi- 
nation of acoustic free-field frequency response in Figure 12. 
ACUTE CLINICAL STUDIES 
Studies in Volunteers with Normal Hearing 
Transducers were inserted into EACs of individuals with normal hearing 
(Fig. 13). For this purpose, a manipulator was fixed to a head holder. With the 
manipulator the transducer coupling rod was attached to the malleus in the intact 
ear drum. Then music from a compact disk (CD) was played. Initially, the high- 
frequency range was too high, an effect which could be attributed to the first me- 
chanical resonance frequency as being around 10 kHz. This effect could be reduced 








-40 I I 
- 
- 




100 1000 10000 Hz 
Frequency 
Figure 12. Acoustic free-field frequency response of the sensor. Sensor was implanted in a 
fresh temporal bone (see Fig. 11). Lmik = 0 dB corresponds to a sensor sensitivity of 3 m V/Pa. 
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Figure 13. Human studies. A, Phase I study. B, Acute study during tympanoplasty. 
with a low-pass limitation of 8 kHz; the resulting sound quality could then no 
longer be distinguished from the free-field presentation of the CD.33 
Studies in Patients with Hearing Loss 
In routine tympanoplasties, actuators were acutely coupled to the ossicular 
chain of 28 patients (Fig. 13). In five patients a sensor was implanted together with 
the actuator beneath the skin of the EAC, allowing the skin to cover the micro- 
phone membrane ~ompletely.~~ Pure-tone thresholds in a broad frequency range 
(250 Hz-8 kHz) and presentation of music allowed psychoacoustic evaluation of 
the transfer properties. The piezoelectric transducer reached an equivalent SPL of 
145 dB up to 10 kHz. Dynamics reached 32 dB, similar to preoperative controls 
using high-fidelity headsets (33 dB). Eighty-four percent of the patients involved 
gave a positive evaluation of the sound quality. Using the sensor all patients could 
hear with the system. When speech and music were presented under free-field 
conditions (65 dB SPL), understanding of the phonetically balanced speech ma- 
terial was 100%. Presentations of music were judged as “clear and undistorted 
with all broadband components.” One patient declared the music to be ”slightly 
unnatural.” 
CLINICAL EXPERIENCE 
Since 1998 the TICA version LZ 3001 has been in use in Europe.55 It is approved 
(CE certification) for routine surgery of moderate to severe high-frequency SNHL. 
The Clinical Implant 
The TICA LZ 3001 consists of three implantable modules (Fig. 14): piezoelectric 
actuator with broadband transmission and low energy consumption, an implant- 
able membrane sensor, and the processor module that includes an implantable 
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Figure 14. Clinical TlCA implant according to Leysieffer-Zenner. A, Coupling to long incus 
process. B, Coupling to incus body and optional reversible malleus neck dissection (reversible 
malleus neck dissection (RMND), Fig. 16). C, Implant with actuator (right), sensor (top) and 
main module (includes battery and microprocessor). D, Radiograph of TlCA implanted in a 
patient. 
battery and an implantable, digitally programmable, three-channel audioprocessor. 
The transducer, placed in the mastoid cavity, is coupled to the incus, and the sensor 
is implanted subcutaneously in the posterior bony wall of the auditory canal. The 
processor module is implanted subcutaneously behind the ear in a recess created in 
the squamosal portion of the temporal bone. Suitable titanium coupling elements 
transfer the mechanical oscillation to the incus. 
Effect of Total Implantation 
The purpose of total implantation is to help patients enjoy more freedom in 
everyday life (eg ,  in taking a shower, walking in the rain, hearing the baby during 
the night). Sporting activities (swimming, diving, and so forth) are possible with 
the implant in use. As discussed earlier, total implantation may have a strong effect 
on professional life. 
Actuator 
The heteromorph, piezoelectric 0.4 g actuator (see Figs. 1,14) is highly tuned 
with a resonance frequency in the range of 7 to 10 kHz, depending on the dynamic 
mass load.21 Below this resonance and down to the low frequencies, the frequency 
response is flat, with a small ripple of less than f l  dB. Vibration amplitude at low 
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to middle frequencies is about 80 nm with a transducer voltage of 1 V. Nonlinear 
distortions at maximumvolume (1 V) are small (THD < 0.1%) throughout the whole 
transfer range. Because of the short attack (c  50 ps )  and release time (approximately 
1 ms), the dynamic properties of the transducer may contribute to clear transmission 
of audio signals with fast changes in the time domain (i.e., plosives in speech 
signals). Electric power consumption at full volume and broadband signals is in 
the region of 1 pW. 
Sensor 
The hermetically sealed implantable 0.4 g sensor (see Figs. 1, 14) possesses a 
sound-pressure transfer function that shows a small r i~ple . ’~ Bandwidth is approx- 
imately 10 kHz. Because of its high tuning and high no-load resonance frequency, 
the sensor is remarkably insensitive to postsurgical changes of the loading mass on 
the microphone membrane caused by the skin’s covering the auditory canal. The 
sound-pressure transfer factor at 1000 Hz is approximately 3 mV/Pa. Because of 
the reduced mass, the sensor is also insensitive to most environmental influences. 
Implantation of the sensor in the auditory canal allows the patient to take advan- 
tage of the directional functions of the outer ear and contributes to the suppression 
of background noise  signal^.^ 
Processor and Battery 
The processor module (Fig. 14) contains the signal-processing electronics and 
an integrated batteryz5 Basic audiologic features are provided by a flexible, digi- 
tally programmable three-channel system with an automatic gain control (AGC) 
with a peak-clipping function. Total bandwidth is around 10 kHz. Because of 
its limited lifetime, the battery must be changed after 3 to 5 years. Leaving the 
transducer and microphone in situ, the processor unit with the battery can be re- 
placed during minor surgery under local anesthesia. This isolated replacement of 
the processor module is made possible by coimplanted plug connections. With 
technical progress, the battery lifetime will probably be prolonged from 5 years to 
10 years. 
Fixing the Actuator 
Conventional miniosteosynthesis plates (1-mm thick, 2-mm wide) were mod- 
ified to create a fixing system for the actuator (see Fig. 1). The system should be 
placed above the mastoid cavity and should deviate no more than 30” (frontal or 
nuchal) from the 0” direction (cranial).’O 
Integrated Micromanipulator 
For safe manipulation of the actuator probe tip to the ossicular chain, a 0.7-g 
titanium micromanipulator was integrated between the fixing plate and actuator. 
The micromanipulator includes a ball-and-socket joint combined with a linear axis 
(see Fig. 1, 14). The ball is kept between the fixing plate and a clamp plate. In the 
resulting ball-and-socket joint, three rotational degrees of freedom can be effected 
with an Allen wrench. The linear axis is attached to the moveable ball. A sliding 
carriage can be conducted precisely along the linear axis. The actuator is elastically 
fixed to the sliding carriage. The sliding carriage can be positioned manually with 
a screwdriver. With the resulting four degrees of freedom, the manipulator allows 
highly secure and safe positioning of the transducer’s probe tip to the ossicular 
chain under nearly stereotactic conditions.” 
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Coupling the Actuator to the Auditory System 
The intended sites for coupling the actuator to the auditory system include the 
long incus process or incus body, the head of the stapes when the incus is missing, 
and the perilymph when the stapes suprastructure is missing. 
For cou ling to the long incus process, several coupling elements have been 
developed,' The clinical version is a bendable titanium rod with an elastic titanium 
clip at its end (see Fig. 1). A ball-and-socket joint allows operation of the clip. A 
bell-shaped element is under development for coupling to the head of the stapes 
that was derived from the Tiibingen titanium prosthesis (TTP) (Kurz, Dusslingen, 
Germany) for ossiculoplasty when the incus is missing. If the stapes suprastructure 
is missing, the coupling rod is inserted as an artifical long incus process through 
a posterior tympanotomy into the oval niche. After perforation of the footplate, 
a conventional piston prosthesis may be positioned as in stapedotomy and fixed 
to the coupling rod. Clinically, coupling to the stapes head and perilymph is not 
yet possible. For coupling to the incus body, two methods seem to be suitable. 
The microapplication of minute amounts of CE-approved surgical cement (e.g., 
Biocem) creates a firm connection between the coupling rod and the incus body. 
The rod can be also be led into a depression in the incus5* l8 that is created with a 
laser (COz, Erb:YAG, or KTP) (see Figs. 1,14). 
!? 
Biocompatibility and Biostability 
All TICA components are made of certified, biocompatible materials. Both 
transducer and sensor are sealed by welding and checked for hermetic gas tightness 
according to MIL STD 883 D. This technology corresponds to that used in modern 
pacemakers and cochlear implants. Corrosion effects are therefore not expected, 
even many years after implantation. Microphone and transducer are thus designed 
for lifelong use in the patient. 
Resistance Against Environmental Influences Including 
MR Imaging and Roentgenograms 
The transducer weighs no more than 0.4 g and thus has a very low dynamic 
mass. This low mass makes it resistant to external mechanical influences such as 
vibrations and knocks. Because the transducer is made of pure titanium with a 
magnetic susceptibility of 1, no mechanical forces or torques are produced under 
the influence of large static magnetic fields. Thus, the device is insensitive to high 
magnetic fields arising in modern MR tomographs. Computed tomography (CT) 
scans and radiographs are possible (Fig. 140). Impairment in the piezoceramic 
electromechanical activity can be expected only in the presence of high tempera- 
tures or excess mechanical strain. Because the transducer is run at a constant, and, 
for this material, low temperature (body temperature), without any extreme strain 
being imposed, no reduction of the electromechanical transduction factor and thus 
loss of the equivalent output level is foreseen, even after 10 years. There is likewise 
little risk of electrical depolarization, because the transducer is used with a maxi- 
mum signal voltage of 1 to 2 V only at electrical field strengths that are well below 
the depolarizing maximum field strength. Because the transducer does not contain 
active electronic components, any risks arising through external electromagnetic 
influences can be almost completely ruled out. The piezoceramic is insensitive to 
electrostatic discharge because of its capacitive behavior, so a danger potential dur- 
ing implantation (contact with the electrical connection poles in the conductor) can 
also be ruled out. 
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The transducer has an inner volume that is hermetically sealed by a metal 
membrane and is gas-filled. Air pressure variations in the mastoid cavity can lead 
to a displacement of the casing membrane. With measuring techniques that take 
into consideration the construction, the thickness of the membrane, and the material 
used, it was demonstrated that the displacement of the membrane held within a 
1-pm range at external pressure changes equivalent to a depth of 5 m in water as 
well as up to about 4000 m above sea level. Thus, a risk for either the piezoceramic 
material and the mechanically coupled inner ear can be ruled out. 
Implantation Technique 
The TICA is implanted through a retroauric approach. Starting 1 cm above 
the tip of the mastoid a basally stemmed retroauric C-shaped skin flap is created 
avoiding the processor module to be positioned directly beneath a skin suture (see 
Fig. 2). Subsequently, an apically based periosteal flap is formed. Mastoidectomy is 
performed in the usual manner. For incus coupling, the surgeon has two options: 
coupling to the long incus process or coupling to the incus body. For coupling to the 
long incus process, a typical posterior tympanotomy with or without preparation of 
the facial nerve is required. Then, a bony recess is created in the squamosal portion 
of the temporal bone behind the ear, leaving the tabula interna intact. In addition, 
a trepanation is created in the posterior wall of the bony external auditory canal, 
allowing the subcutaneous insertion of the sensor membrane (Fig. 15B). 
When placing the actuator in the mastoid, the surgeon uses the positioning 
system to keep the actuator away from the incus, thus minimizing risk for the 
ossicular chain. After screwing the fixing plate to the skull, the actuator module is 
firmly fixed. By using the integrated positioning system, however, the transducer 
itself can be manipulated precisely. To couple the transducer to the long incus 
process (Fig. 15), the clip is maneuvered into a position just over the long incus. 
Holding the incus with a 90" needle the surgeon affixes the clip to the long incus 
process. To couple to the incus body (Fig. 15) a conical indentation of approximately 
0.5 x 0.5 nun is created in the incus body. Using the positioning system, the surgeon 
slowly inserts the transducer until the conical tip of the coupling rod fits into the 
newly prepared conical hole in the incus. Forward movement of the coupling rod 
is halted when a slight movement of the incus is seen that results in a pretension of 
the ossicular chain. A drop of liquid ionomeric cement is recommended to secure 
the coupling. 
Finally, the electronic module is introduced into the bony recess in the squa- 
mosal portion of the temporal bone (Fig. 15) and fixed by surgical suture as in a 
routine CI procedure. The leads from transducer and sensor are then connected 
with the electronic module by plug connections (see Fig. 1). 
To optimize the micromechanical inner ear stimulation by an active vibratory 
hearing implant (i.e., the TICA) coupled to the ossicular chain, a reversible malleus 
neck dissection (RMND) offers a microsurgical option (Zenner et al, unpublished 
data). In selected patients RMND may result in significantly increased loudness be- 
cause sound energy is no longer lost through the ear drum (an intact ossicular chain, 
when vibrating, will also vibrate the ear drum). Instead, energy may be focused 
to the inner ear. Reversible malleus neck dissection may also effectively suppress 
unwanted feedback. The RMND procedure is reversible, because the resulting in- 
terruption may easily be reconstructed at any time using a specifically shaped piece 
of bone or ceramic material or by using bone cement. Usually RMND is performed 
as a secondary procedure (i.e., weeks or months after primary surgery). It involves 
the creation of a tympanomeatal flap, followed by cutting of the malleus neck near 
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Figure 15. Surgical procedure. A, Coupling to the long incus process. 6, Insertion of mem- 
brane sensor. C, Coupling to incus body. 0, Final view of implant coupled to incus body. 
the malleus head using a laser (Erb:YAG, CO2, or KTP) or a cutting instrument 
(Fig. 16). Subsequently, 1 to 1.5 mm of bone from the malleus handle is resected, 
followed by relocation of the tympanomeatal flap. 
Handling by the Patient 
A wireless, inductive remote control (Fig. 17) allowing a selection of four pro- 
grams, volume adjustment, and the possibility of switching the device on and off 
gives the patient a number of options.25 The battery in the processor unit is an 
accumulator cell that can be recharged inductively through a transmission coil 
transcutaneously using a portable recharging unit. For a running time of 50 hours, 
recharging for approximately 2 hours is necessary. The time course is not fixed. A 
patient who uses the implant can decide when and for how long to recharge the 
battery and can plan the day accordingly (most patients recharge 45 minutes daily 
while watching television). Internal safety features prevent the individual recharg- 
ing process from leading to overcharging or to acute depletion of the implanted 
accumulator cell. During the recharging process, the patient can still hear with the 
TICA system. 
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Figure 16. Reversible malleus neck dissection (RMND). May be performed using a COP laser 
(Sharplan, Tel Aviv, Israel). RMND may be restored using a drop of liquid cement (From 
Zenner et al, 2000; with permission). 
Figure 17. Postoperative care. A, Microscopy of external auditory canal. B, Telemetrical fitting 
of the implant using a PC-based adjustment software. C, Wireless, battery-driven remote 
control for the patient. 
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Audiologic Fitting 
Fitting of the implanted, digitally programmable, three-channel audioproces- 
sor to the individual impairment of the inner ear by the audiologist is performed 
by means of the same inductive, transcutaneous data interface used for the remote 
control (Fig. 17). Data are transmitted through the intact skin to a receiving coil in 
the implanted processor unit. The interface is connected to a personal computer. 
Fitting starts no earlier than 8 weeks after implantation, and several sittings are 
usually required for fine tuning. Before surgery patients must be informed that 
weeks or months may be required before they adjust to the new pattern of sound 
and learn new recognition cues. The TICA system allows repeated programming 
to accomodate hearing alterations that may arise later (e.g., a need for greater func- 
tional gain required by a progressive hearing impairment). 
Clinical Study Results 
In a controlled prospective clinical study the TICA version LZ 3001 was totally 
implanted in 20 patients with moderate to severe SNHL (Zenner et al, unpublished 
data)?6 All patients had suffered from chronic bilateral moderate to severe SNHL 
and had not benefited from hearing aids. Nineteen patients were per-protocol (PP) 
patients after a 6-month follow-up. In selected patients binaural pure-tone hearing 
threshold levels (HTL) in the free-sound field revealed maximum functional gains 
of 40 dB at 2 kHz, 50 dB at 3 kHz, and 55 dB at 4 kHz (Fig. 18). For daily use, 
however, the TICA implants were adjusted to the most comfortable loudness levels 
(MCLs) using categorical loudness scaling. Thus, median functional gain was lower. 
Median functional gains at 2000 to 4000 Hz were to 20 dB with an upper interquartile 
limit of 30 dB at 3 kHz. In a subgroup of 17patients for whom preoperative loudness 
scaling was available, pre- and postoperative comparisons were performed. In 14 
patients the desired shift in the characteristic loudness curves could be seen in the 
frequencies involved in conversational speech (between 1000 and 4000 Hz). The 
gain was most obvious at 3150 Hz, at which'frequency a normalization could be 
observed in 12 patients (71%). 
Median HTLs from 1.5 to 4 kHz that did not fall into the long-term speech 
spectrum (LTSS) when the implant was switched off all tallied with the LTSS of 
normal conversational speech after the TICA was turned on. The resulting articu- 
lation index (AI) that establishes a patient's speech energy revealed a statistically 
significant increase (Wilcoxon, P f 0.05) from 14% (median +17%, -12%) with the 
implant off to 32% (median +l6%, -16%) with the implant switched on. 
Using Freiburg phonetically balanced monosyllables (Fig. 18B) a statistically 
significant increase (Wilcoxon, P 5 0.05) of the average word recognition score 
(WRS) from 42% (median +27, -12) to 72% (median +19, -14%) was observed. 
Eighteen patients (95%) showed improvements of the SPL of the best preoperative 
WRS (dB,,). In 11 patients (58%) dB, had the ideal level of 65 dB. Of the 16 pa- 
tients who had suffered from a preoperative speech discrimination loss (with a 
median value of 20% f lo"/.), 14 (88%) showed an improved ability to discriminate 
monosyllables at the end of the study. Eleven patients (69%) with a preoperative 
discrimination loss reached a word recognition ability of 100% after the opera- 
tion. When investigating conversational speech from the front in the Gottingen 
sentence test, 10 patients (56%) exhibited a 100% sentence recognition in quiet 
at a signal level of 65 dB, rising to 14 patients (78%) at a SPL of 75 dB. In the 
presence of noise from the front 13 patients (72%) reached sentence recognition 
thresholds (50% correct) at signal-to-noise ratios between -2 dB and +1 dB. A 90" 
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spatial separation of the speech signal from the noise (with the noise directed to 
the unaided ear) resulted in a significant increase (Wilcoxon, P 5 0.05) of sentence 
recognition from 50% (median +13, -23) to 86% (median +lo, -13). The results in- 
dicate that in these patients a speech intelligibility adequate for rehabilitation was 
achieved. 
Of further interest was the determination of directional hearing ability in a 
low-reflection room (Fig. 18C). Perfect spatial orientation in the room was possible 
in 89.5% of the tasks (persons with normal hearing reached 99.8%). Almost all the 
errors occurred in discriminating front from back. Close inspection revealed that 
faults occurred mainly on the contralateral (unaided) side, whereas the ear aided 
by TICA made mistakes in only 3% of the cases. 
Visual analog scales (VASs) revealed a median sound quality (i.e., spectrum, 
pitch) that improved from a median of 70% (-4o%, +So%) preoperatively to an 
optimum of 100% (+O'XO, -20%) postoperatively. The clarity (absence of distortion) 
of the sound perception improved from a median of 60% (-35%, +30%) preoper- 
atively to a remarkable median value of 95% (+5%, -loo/,) postoperatively. The 
subjective loudness impression was described postoperatively as normal in 62% of 
patients, as too low in 22%' and as too loud in 16%. In the standardized Gothenburg 
profile (Fig. NO), patients reached average values of 80% to 88% (preoperative val- 
ues were 52%-60%) of the maximal scores possible for comprehension, localization, 
social communication, and self-confidence. Thus the reduction of impairment in 
social relationships and self-confidence are as great as the gain in speech com- 
prehension and directional hearing. This statistically significant result (Wilcoxon, 
P 5 0.05) is remarkable and is unlike the results in patients who have been supplied 
with conventional hearing aids. Social retreat may be halted, and the quality of life 
seems to have risen to a large degree. Interestingly, the average daily use of the 
TICA, amounting to 15.5 f 3.4 hours in the per-protocol patients, clearly exceeds 
the 5 to 6 hours that patients use conventional hearing aids, arguing for the efficacy 
of the TICA. 
Adverse Effects 
Adverse effects caused by the implant occurred but were minimal. These effects 
were correctable scar formation in the auditory canal, postoperative seroma, tem- 
porary threshold shift of bone conduction, reinstatable interruption of the incudo- 
stapedial joint, and cases of partial skin necrosis above the microphone membrane 
that could be treated with fascia. Complications, either moderate, severe (such as 
permament threshold shift or facial paralysis), life-threatening, or fatal, brought 
about by implant or surgery did not occur. Termination of the therapy because 
of safety or tolerance problems was not necessary. Any adverse effect measured 
against the benefit for the patient could be justified and did not affect the protection 
of the patients' health and safety. 
STUDY SUMMARY 
The study demonstrated the clinical efficacy of the totally implantable TICA 
in most of the patients treated, none of whom had benefitted from conventional 
hearing aids. The study showed efficient transmission of the signal emitted by the 
TICA to the middle ear ossicles right up to the cochlea in most, but not all, patients. 
Further clinical experience and better understanding of the best way to couple 
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Figure 18. Results of prospective clinical study (n = 20). A, Functional gain (difference of 
postoperative unaided and aided binaural free-field thresholds) with TlCA programmed for 
a most comfortable setting (n = 19 patients). Thin line = median values and interquartile 
ranges; Thick line = maximum functional gain. B, Six months’ postoperative speech discrim- 
ination results using a monosyllabic test (Freiburg test), n = 19 patients, median values and 
interquartile ranges. 
Illustration continued on opposite page 
an implant to the auditory system are needed to improve the overall success rate 
and specifically to improve the percentage of patients achieving hearing at normal 
volume. 
PATIENT SELECTION 
Lack of Benefit from Conventional Hearing Aids 
Patients who benefit from conventional hearing aids do not need a hearing am- 
plifier implant. There are, however, hearing-impaired patients whom hearing aids 
do not help. A recent investigation (Table 1) of patients prossessing hearing 
aids showed underlying problems such as pressure-induced skin lesions, skin 
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Figure 18 (Continued). C, Spatial hearing: left column shows correct answers, right 3 columns 
show errors. 0, Quality of life evaluation (Gothenburg profile) for the preoperative unaided, 
preoperative aided (conventional hearing aids) and postoperative aided (TICA) condition. 
inflammations, feedback, strong background noise, uncomfortable loudness lev- 
els, insufficient amplification, low speech comprehension, too frequent use of re- 
mote controls, or hearing aid defe~ts.4~ Furthermore, a study was performed in 
which hearing aid nonusers underwent fittings of high-performance hearing aids. 
Audiometry and structured interviews allowed investigators to collect data as to 
Table 1. FREQUENCY OF PROBLEMS WITH HEARING AIDS 
Percentage Encountering Problem 
Problem Very Often Seldom Rare 
pressure-induced skin lesions 
skin inflammation 
feedback 
strong background noise 
uncomfortably loud 
too quiet 
low speech comprehension 

































Data From Test Z ,  Leserumfrage. 12:8%91,1999. 
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why some of these patients could not benefit from fitting a hearing aid (unpublished 
data). Results are summarized later. 
Audiologic Criteria 
To determine specific audiologic selection criteria, a prospective clinical in- 
vestigation compared three TICA patient groups (A, B, and C) (Table 2) based on 
their pure-tone audiograms and speech discrimination scores. The audiologic as- 
sessment tests included speech audiometry (monosyllables) as primary efficacy 
variables and sentence recognition, pure-tone audiometry, functional gain, artic- 
ulation index, auditory orientation, and subjective evaluation using standardized 
questionnaires and visual analog scales as secondary efficacy variables (Fig. 19). 
In group A the main efficacy variables revealed more than 90% median word 
recognition at 65 dB and 100% word recognition at higher SPLs. When the dB,, 
was shifted to lower levels, group A achieved a shift to the speech SPL of 65 dB in all 
cases. In all groups a previous discrimination loss could be completely eliminated. 
Average WRS of groups A and B showed a median increase from 42% (+27, -12%) 
to 93.5% (+3, -5%) and to 92.5% (+3, -7%) respectively. Among the secondary 
efficacy variables, almost all the standardized sentences were understood in quiet. 
In the presence of background noise, the sentence-recognition threshold ranged 
from -2 to 1 dB signal-to-noise ratio. Maximal functional gain was 55 dB at 3 kHz. 
The articulation index doubled. In the horizontal plane, directions were localized 
correctly by 89.5% of patients. In groups A and B, visual analog scales revealed 
maximum scores of 100% for both natural sound impression and clarity. Before 
surgery sound impression had reached no more than 70% and clarity no more than 
62.5% (group A) or 70% (group B) of the maximal rating. With the standardized 
Gothenburg profile subjective evaluation of hearing, orientation, social behavior, 
and self-confidence, group A reached values of 96% to 98%, group B reached 92% to 
96%, and group C reached 84% to 92% of the maximum score. The results suggested 
that the preoperative audiometric pure-tone parameter of group A could be used 
as a patient selection criterion. 
Imaging Criteria 
Implantation of a TICA requires a minimum mastoid volume. Thus, using con- 
ventional radiographs and CT scans, the authors analyzed 50 cadaver specimens 
of the temporal bone before total mastoidectomy. After total mastoidectomy, the 
volume of the mastoid cavity was measured using CT scans and water volume 
determination. Finally, the TICA device was implanted into those temporal bones 
Table 2. PATIENT GROUPS 




High-frequency SNHL, maximum low-frequency HL 30 dB at 
0.5 kHz. 30 dB difference between 0.5 kHz and 2 kHz. 
Minimum of 10% word recognition at 60 dB. Maximum 
discrimination loss of 30%. 
Word recognition at 60 dB plus word recognition at dB,, result 
in a minimum value of 90%. 
SNHL = sensorineural hearing loss; HL = hearing level. 
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that were large enough to house it. The results demonstrated that the degree of 
pneumatization in the conventional Schuller’s radiograph was a reliable parame- 
ter for preoperative evaluation.28 For TICA implantation, normal pneumatization 
is required. 
Summary 
A TICA implantation may be indicated when a patient fulfills three selection 
criteria: lack of benefit from conventional hearing aids, moderate to severe high- 
frequency SNHL, and adequate space in the mastoid for implantation. 
Lack of Benefit from Conventional Hearing Aids 
Medical and psychosocial problems include 
Intolerance of the occlusion of the auditory canal by the ear-fitting device 
Ear-mold-induced repeated inflammation and pressure-induced skin le- 
Manual motor impairment (e.g., from tremor or paralysis) making the daily 
Discrimination resulting from use of a visible hearing aid 
Auditory problems include 
Intolerable feedback 
Distortion, low speech comprehension, strong amplification of background 
Reduced ability to communicate in the presence of background noise (party 
Steep slope of hearing loss 
Professional problems can be experienced by 
Musicians 
Professional athletes, sports instructors 
Language professionals (translators, language teachers) 
Persons whose work requires the use of earphones or stethoscopes 
Persons whose professional activities require telephone use and who cannot 
conduct telephone conversations using a conventional hearing aid 
Persons whose activities are associated with heat, sweat production, fat pro- 
duction, steam production, or dust production that can result in loss or dam- 
age to conventional hearing aids. 
sions of the external auditory canal 
use of tiny hearing aids or the use of tiny elements impossible 
noise 
effect) 
Moderate to Severe High-frequency Sensorinueral Hearing Loss 
Maximum high frequency hearing loss (23 kHz) may be 90 dB (Fig. 20). Max- 
imum low-frequency hearing loss should be no more than 30 dB at 0.5 kHz. In 
addition, the slope of hearing loss between 0.5 and 2 kHz should be 30 dB or more. 
The difference between the two ears should be no more than 20 dB (Zenner et al, 
unpublished data). 
Schuller’s Radiograph 
The Schuller ’s radiograph should display normal mastoid pneumatization.28 
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Figure 19. Results of patients selected according to the criteria in Figure 20. A, Functional 
gain (difference of postoperative unaided and aided binaural free-field thresholds) with TlCA 
programmed for a most comfortable setting. Thick line = median values and interquartile 
ranges; thin line = maximum functional gain. 6, Threshold transfer into long-term speech 
spectrum. 
Illustration continued on opposite page 
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Figure 19 (Continued). C, Word recognition. D, Gothenburg profile before and after surgery. 
Figure 20. Indications for TlCA LZ 3001. Moderate to severe high frequency SNHL up to 90 dB 
at 23 kHz. Maximum low frequency hearing loss should be no more than 30 dB at 0.5 kHz. In 
addition, the slope of hearing loss between 0.5 and 2 kHz should be 30 dB and more. Missing 
benefits from conventional hearing aids include medical problems, psycho-social problems, 
audiologic problems, professional problems. Mastoid with normal pneumatization. 
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